Evotec SE (EVO) Total Current Liabilities (2009 - 2026)
Evotec SE's (EVO) quarterly Total Current Liabilities came in at $363.2 million in Q2 2026, down 16.27% year-over-year from $433.7 million in Q2 2025, and down 26.73% quarter-over-quarter from $495.7 million in Q1 2026.
Analysis
Evotec SE (EVO) Total Current Liabilities (2009 - 2026) Analysis & Trends
Evotec SE has disclosed Total Current Liabilities across 9 years of filings, most recently posting $363.2 million for Q2 2026.
- In Q2 2026, Total Current Liabilities fell 16.27% year-over-year to $363.2 million; the TTM figure through Jun 2026 stood at $363.2 million (down 16.27% YoY), while the FY2025 annual figure was $415.9 million, up 11.5% from the prior year.
- Total Current Liabilities came in at $363.2 million for Q2 2026 at Evotec SE, down from $495.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $531.5 million in Q2 2023 to a low of $343.6 million in Q3 2022.
- Average Total Current Liabilities over 5 years is $413.0 million, with a median of $381.2 million recorded in 2022.
- Year-over-year, Total Current Liabilities surged 45.08% in 2023 and declined 26.33% in 2024.
- Over 5 years, Total Current Liabilities stood at $344.5 million in 2022, then surged by 45.08% to $499.9 million in 2023, then dropped by 26.33% to $368.2 million in 2024, then gained by 16.36% to $428.5 million in 2025, then decreased by 15.23% to $363.2 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $363.2 million in Q2 2026, $495.7 million in Q1 2026, and $428.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 8.82 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 1.44 Bn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 1.13 Bn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 3.93 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 963.70 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | 363.19 Mn |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 72.74 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 19.92 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 4.22 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 1.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 363.19 Mn |
| Mar 31, 2026 | 495.66 Mn |
| Dec 31, 2025 | 428.45 Mn |
| Sep 30, 2025 | 437.77 Mn |
| Jun 30, 2025 | 433.75 Mn |
| Mar 31, 2025 | 375.44 Mn |
| Dec 31, 2024 | 368.22 Mn |
| Sep 30, 2024 | 366.39 Mn |
| Dec 31, 2023 | 499.85 Mn |
| Jun 30, 2023 | 531.51 Mn |
| Dec 31, 2022 | 344.54 Mn |
| Sep 30, 2022 | 343.62 Mn |
| Mar 31, 2022 | 381.17 Mn |
| Dec 31, 2021 | 371.24 Mn |
| Sep 30, 2021 | 299.28 Mn |
| Dec 31, 2020 | 248.54 Mn |
| Sep 30, 2010 | 35.83 Mn |
| Jun 30, 2010 | 32.22 Mn |
| Mar 31, 2010 | 32,965.79 |
| Dec 31, 2009 | 39.05 Mn |